The pharmaceutical giant has agreed to a $2.2bn (£1.68bn) settlement to resolve lawsuits in the US alleging that the ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

Experts have warned that offering no support to women dealing with menopause symptoms such as anxiety, depression, extreme ...

Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up ...

GSK Plc CEO Emma Walmsley doesn’t want the company’s employees spending any time thinking about the ongoing litigation over its old heartburn drug Zantac, an issue that has weighed on the ...

"They say in the trial, 'All you need to know is the science and we win,' and that argument ... which will be the first Zantac trials in California." GlaxoSmithKline didn't admit liability in ...

The case, brought by Illinois resident Ronald Kimbrow, alleged that Zantac caused his prostate cancer after he took the drug from 1995 to 2019. The sole defendant in the trial was German drugmaker ...

In Delaware, the top court is rehearing the trial court’s evidentiary ruling admitting plaintiffs’ experts’ testimony in the Zantac cases ... while individual plaintiffs have scored wins in Roundup ...

The privately held German drugmaker was the only defendant at the trial in Cook County Circuit Court, after plaintiff Ronald Kimbrow settled with others including GSK, which originally developed the ...

(Reuters) – The latest trial over claims ... settled with others including GSK, which originally developed the drug, and Pfizer. Kimbrow, 73, said he took Zantac from 1995 to 2019.